Fig. 3: Known-groups validity: number and outcome of eligible studies assessing differences in DMOs between patients and healthy controls. | npj Digital Medicine

Fig. 3: Known-groups validity: number and outcome of eligible studies assessing differences in DMOs between patients and healthy controls.

From: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes

Fig. 3

PD Parkinson’s disease, MS multiple sclerosis, COPD chronic obstructive pulmonary disease, PFF proximal femoral fracture. Data are presented as: Number of studies with statistically significant differences between groups/Total studies (%). DMOs known to be highly intercorrelated were grouped (i.e., step length and stride length), and all DMOs were organized according to previously established domains of gait. *Proportion of studies exceeds the expected false-positive rate as determined by Bernoulli hypothesis testing and Benjamini–Hochberg adjustment.

Back to article page